Long-term survival and quality of life: results from the United States Chronic Thromboembolic Pulmonary Hypertension Registry
KM Chin, WR Auger, RL Benza, RN Channick… - CHEST Pulmonary, 2023 - Elsevier
Background Chronic thromboembolic pulmonary hypertension (CTEPH) causes significant
morbidity and mortality, but long-term outcomes from contemporary multicenter studies are …
morbidity and mortality, but long-term outcomes from contemporary multicenter studies are …
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis …
J Minhas, SP Narasimmal, T M. Bull… - Pulmonary …, 2021 - journals.sagepub.com
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, morbid, potentially
curable subtype of pulmonary hypertension that negatively impacts health-related quality of …
curable subtype of pulmonary hypertension that negatively impacts health-related quality of …
US CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) REGISTRY: SURVIVAL AND HOSPITALIZATION OUTCOMES
K Chin, S Jain, WR Auger, RL Benza, RN Channick… - Chest, 2022 - journal.chestnet.org
METHODS: Patients with CTEPH diagnosed within 6 months of enrollment were recruited
from 30 US sites between April 2015 and March 2017. Patients were classified as operated …
from 30 US sites between April 2015 and March 2017. Patients were classified as operated …
[HTML][HTML] Results from the United States Chronic Thromboembolic Pulmonary Hypertension Registry: enrollment characteristics and 1-year follow-up
KM Kerr, CG Elliott, K Chin, RL Benza, RN Channick… - Chest, 2021 - Elsevier
Background The United States Chronic Thromboembolic Pulmonary Hypertension Registry
(US-CTEPH-R) was designed to characterize the demographic characteristics, evaluation …
(US-CTEPH-R) was designed to characterize the demographic characteristics, evaluation …
Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service
DG Kiely, N Hamilton, S Wood, C Durrington… - BMJ open, 2024 - bmjopen.bmj.com
Objectives This study was conducted to evaluate the ability of risk assessment to predict
healthcare resource utilisation (HCRU), costs, treatments, health-related quality of life …
healthcare resource utilisation (HCRU), costs, treatments, health-related quality of life …
Chronic thrombo-embolic pulmonary hypertension: Long-term outcomes in operated and non-operated patients
Introduction: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a life shortening
condition that may be cured by pulmonary endarterectomy. However, patients may not …
condition that may be cured by pulmonary endarterectomy. However, patients may not …
Impact of sex, race and socioeconomic status on survival after pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension
AY Su, A Vinogradsky, AS Wang, Y Ning… - European Journal of …, 2022 - academic.oup.com
OBJECTIVES Pulmonary thromboendarterectomy (PTE) is a definitive treatment for chronic
thromboembolic pulmonary hypertension. Demographic-based disparities in PTE outcomes …
thromboembolic pulmonary hypertension. Demographic-based disparities in PTE outcomes …
P183 Impact of patient choice on survival in patients with chronic thromboembolic pulmonary hypertension offered pulmonary endarterectomy
Introduction Chronic thromboembolic pulmonary hypertension (CTEPH) is potentially
curable by pulmonary endarterectomy (PEA). Despite this a significant proportion of patients …
curable by pulmonary endarterectomy (PEA). Despite this a significant proportion of patients …
CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
M Newnham, K Bunclark, N Abraham… - European …, 2020 - Eur Respiratory Soc
Background Pulmonary endarterectomy (PEA) is the recommended treatment for eligible
patients with chronic thromboembolic pulmonary hypertension (CTEPH). The Cambridge …
patients with chronic thromboembolic pulmonary hypertension (CTEPH). The Cambridge …
Hospitalisation is prognostic of survival in chronic thromboembolic pulmonary hypertension
P Jansa, D Ambrož, M Aschermann, V Černý… - Journal of Clinical …, 2022 - mdpi.com
This analysis investigated the prognostic value of hospitalisation in chronic thromboembolic
pulmonary hypertension (CTEPH) using data from the Czech Republic, wherein pulmonary …
pulmonary hypertension (CTEPH) using data from the Czech Republic, wherein pulmonary …